Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Maeshima

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Nephrology and Renovascular Disease|July 17, 2019
Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcomeYuki Kakio, Haruhito A Uchida, Hidemi Takeuchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic miceHitoshi Sugiyama, Mizuho Kobayashi, Da-Hong Wang, et al.
BMC Nephrology|June 26, 2012
A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhoodKenji Tsuji, Haruhito Adam Uchida, Tetsuichirou Ono, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2006
Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathyHaruhito Adam Uchida, Yoshio Nakamura, Masanobu Kaihara, et al.
Diabetes|July 10, 2009
Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathyTatsuyo Nasu, Yohei Maeshima, Masaru Kinomura, et al.
CEN Case Reports|May 17, 2017
Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndromeMasafumi Tenta, Haruhito Adam Uchida, Tomokazu Nunoue, et al.
Diabetes|September 28, 2005
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy modelKunihiro Ichinose, Yohei Maeshima, Yoshihiko Yamamoto, et al.
Clinical and Experimental Nephrology|April 16, 2009
A case of immunotactoid glomerulopathy exhibiting nephrotic syndrome successfully treated with corticosteroids and antihypertensive therapyMasaru Kinomura, Yohei Maeshima, Ryo Kodera, et al.
Physiological Reports|June 29, 2014
Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstructionHiroyuki Watatani, Yohei Maeshima, Norikazu Hinamoto, et al.
Acta Medica Okayama|February 24, 2015
ONO-1301, a sustained-release prostacyclin analog, ameliorates the renal alterations in a mouse type 2 diabetes model possibly through its protective effects on mesangial cellsHiroyuki Watatani, Hiroko Yamasaki, Yohei Maeshima, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Nephrology and Renovascular Disease|July 17, 2019
Report of health checkup system for chronic kidney disease in general population in Okayama city: effect of health guidance intervention on chronic kidney disease outcomeYuki Kakio, Haruhito A Uchida, Hidemi Takeuchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 6, 2005
Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic miceHitoshi Sugiyama, Mizuho Kobayashi, Da-Hong Wang, et al.
BMC Nephrology|June 26, 2012
A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhoodKenji Tsuji, Haruhito Adam Uchida, Tetsuichirou Ono, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 5, 2006
Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathyHaruhito Adam Uchida, Yoshio Nakamura, Masanobu Kaihara, et al.
Diabetes|July 10, 2009
Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathyTatsuyo Nasu, Yohei Maeshima, Masaru Kinomura, et al.
CEN Case Reports|May 17, 2017
Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndromeMasafumi Tenta, Haruhito Adam Uchida, Tomokazu Nunoue, et al.
Diabetes|September 28, 2005
Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy modelKunihiro Ichinose, Yohei Maeshima, Yoshihiko Yamamoto, et al.
Clinical and Experimental Nephrology|April 16, 2009
A case of immunotactoid glomerulopathy exhibiting nephrotic syndrome successfully treated with corticosteroids and antihypertensive therapyMasaru Kinomura, Yohei Maeshima, Ryo Kodera, et al.
Physiological Reports|June 29, 2014
Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstructionHiroyuki Watatani, Yohei Maeshima, Norikazu Hinamoto, et al.
Acta Medica Okayama|February 24, 2015
ONO-1301, a sustained-release prostacyclin analog, ameliorates the renal alterations in a mouse type 2 diabetes model possibly through its protective effects on mesangial cellsHiroyuki Watatani, Hiroko Yamasaki, Yohei Maeshima, et al.
Pageof 7